Monday 03 Mar
The consolidated financial statements of the Egyptian International Pharmaceutical Industries Company - EIPICO, for the past year, revealed that the company's profits increased by 33.23% year-on-year.
In a statement to the Egyptian Stock Exchange today, Sunday, the company clarified that it recorded profits of 1.09 billion Egyptian pounds in 2024, compared to profits of 823.3 million Egyptian pounds at the end of 2023, taking into account minority rights.
Sales rose from 5.23 billion Egyptian pounds in 2023 to 7.59
billion Egyptian pounds in the past year 2024.
On the level of unconsolidated statements, the net profit of the standalone company increased during the past year to 1.02 billion Egyptian pounds, compared to 730.08 million Egyptian pounds in the previous year.
